The White House used its 2026 Economic Report of the President to argue that payment rules, administrative work and market consolidation make it harder for independent physicians to compete. The chapter presents those policies as a route to faster and less expensive care.
It is not a newly enacted physician reform package. The report mainly assembles actions already taken or proposed across Medicare, Medicaid, price transparency, rural funding and prior authorization. That distinction matters because a policy inventory is not evidence that patients' bills have already fallen.
The Report Focuses on Payment Distortions
The central argument is that public payment rules can favor hospital ownership over independent practice. Medicare may pay different amounts for the same service depending on where it is delivered, creating an incentive for hospitals to acquire physician groups and bill under a hospital setting.
The report points to the 2026 hospital outpatient rule, which extends a lower physician-fee-schedule rate to some drug-administration services at off-campus hospital departments. It also cites changes to practice-expense calculations intended to better recognize the costs of independent practices.
Those are targeted payment changes, not a nationwide requirement that every service receive the same rate in every setting. Hospitals can carry emergency capacity, teaching obligations and other costs that offices do not. A credible site-neutral policy therefore has to identify comparable services while protecting access where a higher-cost facility is clinically or geographically necessary.
The report also highlights limits on certain Medicaid state-directed payments. It says 53% of those programs in 2024 directed money to hospitals and 11% to physicians, with the rest going to other facilities. The 2025 budget law caps and phases down some arrangements above Medicare rates. Whether that produces more independent practice or simply removes hospital revenue will depend on state implementation.
Prior Authorization Is Being Changed, Not Eliminated
Prior authorization requires clinicians to obtain insurer approval before specified tests, procedures or medicines are covered. Physicians have long described the process as a source of delay and paperwork, while insurers defend it as a check on unnecessary or excessively costly care.
In June 2025, HHS and CMS announced a voluntary pledge with major insurers to reduce the number of services requiring authorization, standardize electronic requests and expand real-time responses. Separate federal rules require affected Medicare Advantage, Medicaid, Children's Health Insurance Program and federal Marketplace plans to issue urgent decisions within 72 hours and standard decisions within seven calendar days from January 2026. Electronic interfaces are scheduled for 2027.
Those deadlines create measurable obligations for covered plans, but the broader insurer pledge remains voluntary. Administration officials have also said they do not seek to abolish prior authorization. The practical test is whether denials, delays and staff hours fall without removing legitimate clinical review or shifting work into a different administrative channel.
The Economic Report predicts faster approvals and lower administrative costs. It does not present a completed national evaluation showing how much the changes have reduced a typical office visit or a family's out-of-pocket spending.
Competition Policies Extend Beyond Paperwork
The report connects administrative reform with a wider competition agenda. It cites hospital price-transparency requirements, a $50 billion rural health program, fertility-care proposals and payment experiments run through the Center for Medicare and Medicaid Innovation.
One example is the Ambulatory Specialty Model, which is designed to adjust payments for selected specialists according to cost and quality performance across services. The report says the mandatory model will operate in 240 geographic areas and could produce payment adjustments of plus or minus 9% to 12% by 2033.
Calling those arrangements value-based does not guarantee better value. A model can reward efficiency, but it can also penalize practices caring for sicker or less-resourced patients if risk adjustment and quality measures are weak. CMS must show who participates, how patient complexity is handled and whether savings reflect better care or reduced service use.
The rural fund has a similar evidence problem. The administration says it can expand the workforce and redesign care in remote communities. The Washington Post reported criticism that a temporary grant fund cannot by itself solve structural rural access problems, especially against the scale of national health spending and other Medicaid changes.
A Policy List Needs Patient-Level Results
The physician-market chapter offers a coherent theory: reduce payment advantages tied to hospital ownership, make prices more visible, streamline approvals and reward outcomes rather than volume. Several of those ideas have bipartisan support. None deserves a blank check.
Site-neutral payments should be evaluated for patient cost sharing, Medicare spending, practice acquisition and closures. Prior-authorization reform should publish decision times, denial and appeal rates, abandoned care and clinician work hours. Alternative payment models should report outcomes and access by patient risk, disability, income and geography.
Those measures would separate savings from cost shifting. A lower federal payment is not a patient benefit if it closes the only local service. A faster electronic approval is not administrative relief if a practice must maintain parallel systems. A quality bonus is not value if vulnerable patients become harder to accept.
The White House report is useful as a map of the administration's approach, but it repeatedly states expected benefits as outcomes that policies will produce. The hard standard comes afterward. If the government wants credit for cheaper and better physician care, it must publish comparable before-and-after results, not treat a chapter in an economic report as the result itself.